• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超分子环状二核苷酸纳米颗粒用于 STING 介导的癌症免疫治疗。

Supramolecular Cyclic Dinucleotide Nanoparticles for STING-Mediated Cancer Immunotherapy.

机构信息

School of Chemistry and Chemical Engineering, Frontiers Science Center for Transformative Molecules, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, China.

Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai 201203, China.

出版信息

ACS Nano. 2023 Jun 13;17(11):10090-10103. doi: 10.1021/acsnano.2c12685. Epub 2023 May 30.

DOI:10.1021/acsnano.2c12685
PMID:37253192
Abstract

Activation of stimulator of interferon genes (STING) can reprogram the immunosuppressive tumor microenvironment (TME) by initiating innate and adaptive immunity. As natural STING agonists, clinical translation of cyclic dinucleotides (CDNs) has been challenged by their short half-life in circulation, poor stability, and low membrane permeability. Herein, we use the natural endogenous small molecules oleic acid and deoxycytidine to construct a ligand for the STING agonist c-di-GMP (CDG), a hydrophobic nucleotide lipid (3',5'-diOA-dC), which can assemble with CDG into stable cyclic dinucleotide nanoparticles (CDG-NPs) through various supramolecular forces driven by molecular recognition. CDG-NPs are homogeneous and stable spherical nanoparticles with an average diameter of 59.0 ± 13.0 nm. Compared with free CDG, CDG-NPs promote the retention and intracellular delivery of CDG in the tumor site, boost STING activation and TME immunogenicity, and potentiate STING-mediated anti-tumor immunity when administered by either intratumoral or systemic routes in melanoma-bearing mice. We propose a flexible supramolecular nanodelivery system for CDG by using endogenous small molecules, which provides a CDN delivery platform for STING-mediated cancer immunotherapy.

摘要

干扰素基因刺激物 (STING) 的激活可以通过启动先天和适应性免疫来重新编程免疫抑制性肿瘤微环境 (TME)。作为天然的 STING 激动剂,环二核苷酸 (CDN) 的临床转化受到其在循环中半衰期短、稳定性差和膜通透性低的限制。在此,我们使用天然内源性小分子油酸和脱氧胞苷来构建 STING 激动剂 c-di-GMP (CDG) 的配体,即疏水性核苷酸脂质 (3',5'-diOA-dC),它可以通过分子识别驱动的各种超分子力与 CDG 组装成稳定的环二核苷酸纳米颗粒 (CDG-NPs)。CDG-NPs 是均一且稳定的球形纳米颗粒,平均直径为 59.0 ± 13.0nm。与游离 CDG 相比,CDG-NPs 促进了 CDG 在肿瘤部位的保留和细胞内递送,增强了 STING 激活和 TME 免疫原性,并在荷黑色素瘤小鼠中通过瘤内或系统途径给药时增强了 STING 介导的抗肿瘤免疫。我们通过使用内源性小分子为 CDG 提出了一种灵活的超分子纳米递药系统,为 STING 介导的癌症免疫治疗提供了一个 CDN 递药平台。

相似文献

1
Supramolecular Cyclic Dinucleotide Nanoparticles for STING-Mediated Cancer Immunotherapy.超分子环状二核苷酸纳米颗粒用于 STING 介导的癌症免疫治疗。
ACS Nano. 2023 Jun 13;17(11):10090-10103. doi: 10.1021/acsnano.2c12685. Epub 2023 May 30.
2
STING Activator c-di-GMP-Loaded Mesoporous Silica Nanoparticles Enhance Immunotherapy Against Breast Cancer.STING 激活剂 c-di-GMP 负载介孔硅纳米颗粒增强乳腺癌免疫治疗。
ACS Appl Mater Interfaces. 2020 Dec 23;12(51):56741-56752. doi: 10.1021/acsami.0c16728. Epub 2020 Dec 11.
3
Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration.纳米颗粒递呈改善环状二核苷酸 STING 激动剂的药代动力学特性,为静脉给药开辟治疗窗口。
J Control Release. 2021 Feb 10;330:1118-1129. doi: 10.1016/j.jconrel.2020.11.017. Epub 2020 Nov 12.
4
pH-Responsive STING-Activating DNA Nanovaccines for Cancer Immunotherapy.用于癌症免疫治疗的pH响应性STING激活DNA纳米疫苗
Adv Ther (Weinh). 2020 Sep;3(9). doi: 10.1002/adtp.202000083. Epub 2020 Jun 8.
5
Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy.内溶酶体聚合物囊泡提高环状二核苷酸 STING 激动剂的活性,增强癌症免疫治疗。
Nat Nanotechnol. 2019 Mar;14(3):269-278. doi: 10.1038/s41565-018-0342-5. Epub 2019 Jan 21.
6
Polymersome-mediated cytosolic delivery of cyclic dinucleotide STING agonist enhances tumor immunotherapy.聚合物囊泡介导的环状二核苷酸STING激动剂的胞质递送增强肿瘤免疫治疗。
Bioact Mater. 2022 Mar 4;16:1-11. doi: 10.1016/j.bioactmat.2022.02.029. eCollection 2022 Oct.
7
Induction of tumor regression by intratumoral STING agonists combined with anti-programmed death-L1 blocking antibody in a preclinical squamous cell carcinoma model.在临床前鳞状细胞癌模型中,瘤内注射STING激动剂联合抗程序性死亡蛋白1阻断抗体诱导肿瘤消退。
Head Neck. 2017 Jun;39(6):1086-1094. doi: 10.1002/hed.24704. Epub 2017 Mar 21.
8
Identification of Novel Carbocyclic Pyrimidine Cyclic Dinucleotide STING Agonists for Antitumor Immunotherapy Using Systemic Intravenous Route.利用全身静脉途径鉴定用于抗肿瘤免疫治疗的新型碳环嘧啶环二核苷酸STING激动剂
J Med Chem. 2021 May 27;64(10):6902-6923. doi: 10.1021/acs.jmedchem.1c00374. Epub 2021 May 17.
9
PamCSK-CDG Augments Antitumor Immunotherapy by Synergistically Activating TLR1/2 and STING.帕米司他-CD 协同激活 TLR1/2 和 STING 增强抗肿瘤免疫治疗。
Bioconjug Chem. 2020 Nov 18;31(11):2499-2503. doi: 10.1021/acs.bioconjchem.0c00522. Epub 2020 Nov 4.
10
Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity.瘤内 STING 激活与 T 细胞检查点调节产生全身性抗肿瘤免疫。
Cancer Immunol Res. 2017 Aug;5(8):676-684. doi: 10.1158/2326-6066.CIR-17-0049. Epub 2017 Jul 3.

引用本文的文献

1
Nanomaterials Application for STING Pathway-Based Tumor Immunotherapy.基于STING通路的肿瘤免疫疗法中的纳米材料应用
Int J Nanomedicine. 2025 Sep 3;20:10771-10793. doi: 10.2147/IJN.S535460. eCollection 2025.
2
The activation of cGAS-STING pathway offers novel therapeutic opportunities in cancers.cGAS-STING通路的激活为癌症治疗提供了新的机遇。
Front Immunol. 2025 Jun 9;16:1579832. doi: 10.3389/fimmu.2025.1579832. eCollection 2025.
3
Polysaccharide Nanoadjuvants Engineered via Phenotype-Specific Nanoprobe-Assisted Phenotypic Screen Reprogram Macrophage Cell Functions for Cancer and Rheumatoid Arthritis Therapy.
通过表型特异性纳米探针辅助表型筛选工程化的多糖纳米佐剂可重编程巨噬细胞功能用于癌症和类风湿性关节炎治疗。
ACS Nano. 2025 Apr 8;19(13):12920-12936. doi: 10.1021/acsnano.4c16671. Epub 2025 Mar 28.
4
Nanocarrier-mediated modulation of cGAS-STING signaling pathway to disrupt tumor microenvironment.纳米载体介导的cGAS-STING信号通路调节以破坏肿瘤微环境
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb 5. doi: 10.1007/s00210-025-03835-3.
5
Novel Modifications and Delivery Modes of Cyclic Dinucleotides for STING Activation in Cancer Treatment.用于癌症治疗中激活STING的环状二核苷酸的新型修饰和递送方式
Int J Nanomedicine. 2025 Jan 6;20:181-197. doi: 10.2147/IJN.S503780. eCollection 2025.
6
Recent advances in nanoadjuvant-triggered STING activation for enhanced cancer immunotherapy.纳米佐剂触发STING激活以增强癌症免疫治疗的最新进展
Heliyon. 2024 Oct 5;10(20):e38900. doi: 10.1016/j.heliyon.2024.e38900. eCollection 2024 Oct 30.
7
STING Agonist cGAMP Attenuates Sleep Deprivation-Induced Neuroinflammation and Cognitive Deficits via TREM2 Up-Regulation.STING激动剂cGAMP通过上调TREM2减轻睡眠剥夺诱导的神经炎症和认知缺陷。
Inflammation. 2024 Dec;47(6):2129-2144. doi: 10.1007/s10753-024-02029-y. Epub 2024 Apr 26.
8
Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy.用于癌症治疗中免疫调节的纳米材料封装的STING激动剂。
Biomark Res. 2024 Jan 7;12(1):2. doi: 10.1186/s40364-023-00551-z.
9
At the Crossroads of the cGAS-cGAMP-STING Pathway and the DNA Damage Response: Implications for Cancer Progression and Treatment.cGAS-cGAMP-STING通路与DNA损伤反应的交叉点:对癌症进展和治疗的影响
Pharmaceuticals (Basel). 2023 Dec 1;16(12):1675. doi: 10.3390/ph16121675.